MedTrace Logo

Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

NCT07155707 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2025-09-23

No results posted yet for this study

Summary

This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the trial will examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.

Conditions

Interventions

OTHER

Teleo

Therapist-led psychotherapy sessions implemented within the Teleo virtual therapy platform.

OTHER

Standard Videoconferencing

Therapist-led psychotherapy sessions implemented in standard (non-Teleo) video platform.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • MainSquare Co. (dba 'Teleo')

    collaborator UNKNOWN

  • Stanford University

    lead OTHER

Principal Investigators

  • David S Hong, MD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-15
Primary Completion
2027-09-15
Completion
2027-09-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07155707 on ClinicalTrials.gov